Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — U.S. Revenue ($M) ($M)
Medtronic Form 8-K U.S. Revenue Tables
Latest, FY2023
1,418
Period ended Apr 30, 2023
Change on a year earlier
-7.3%
1,529 in FY2022
History
7 years
Since FY2017
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — U.S. Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Apr 30, 2023 | 1,418 | -7.3% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | 1,529 | -1.4% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2021 | Apr 30, 2021 | 1,550 | +12.6% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2020 | Apr 30, 2020 | 1,376 | +4.6% | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2019 | Apr 30, 2019 | 1,315 | +8,275.8% | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2018 | Apr 30, 2018 | 15.7 | -99.0% | Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗ |
| FY2017 | Apr 30, 2017 | 1,559 | – | Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗ |
Cite this data
StockData. (2026). Medtronic Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — U.S. Revenue ($M) ($M), annual FY2017–FY2023 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-rgr-leg-us-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.